Triglav Investments D.O.O. Acquires Shares of 15,000 Tempus AI, Inc. $TEM

Triglav Investments D.O.O. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the first quarter, HoldingsChannel.com reports. The firm bought 15,000 shares of the company’s stock, valued at approximately $678,000.

Several other hedge funds and other institutional investors also recently modified their holdings of TEM. Vanguard Group Inc. raised its holdings in shares of Tempus AI by 8.7% during the 4th quarter. Vanguard Group Inc. now owns 10,258,621 shares of the company’s stock worth $605,772,000 after buying an additional 817,014 shares in the last quarter. ARK Investment Management LLC lifted its position in shares of Tempus AI by 5.3% during the 4th quarter. ARK Investment Management LLC now owns 7,557,583 shares of the company’s stock worth $446,275,000 after buying an additional 381,816 shares during the last quarter. GC Wealth Management RIA LLC acquired a new stake in Tempus AI in the fourth quarter valued at about $399,267,000. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 23.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,326,313 shares of the company’s stock valued at $195,636,000 after buying an additional 821,490 shares in the last quarter. Finally, Amova Asset Management Americas Inc. grew its position in Tempus AI by 1.2% in the fourth quarter. Amova Asset Management Americas Inc. now owns 3,504,823 shares of the company’s stock valued at $206,960,000 after acquiring an additional 41,728 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

Insider Buying and Selling

In related news, CEO Eric P. Lefkofsky sold 166,250 shares of Tempus AI stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total value of $7,763,875.00. Following the transaction, the chief executive officer directly owned 8,808,533 shares of the company’s stock, valued at $411,358,491.10. The trade was a 1.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Ryan Fukushima sold 33,284 shares of the company’s stock in a transaction that occurred on Wednesday, July 8th. The shares were sold at an average price of $57.39, for a total value of $1,910,168.76. Following the completion of the sale, the chief executive officer owned 167,763 shares in the company, valued at $9,627,918.57. The trade was a 16.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 616,043 shares of company stock valued at $31,748,593 over the last three months. 24.26% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have commented on TEM shares. Jefferies Financial Group began coverage on Tempus AI in a research note on Monday, April 13th. They set an “underperform” rating and a $35.00 target price for the company. Freedom Capital raised shares of Tempus AI to a “hold” rating in a report on Tuesday, June 30th. Wolfe Research began coverage on shares of Tempus AI in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. HC Wainwright dropped their price objective on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a research note on Monday, May 11th. Finally, TD Cowen increased their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Nine analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $68.54.

Tempus AI Stock Performance

NASDAQ TEM opened at $58.23 on Monday. The company has a market capitalization of $10.46 billion, a price-to-earnings ratio of -33.85 and a beta of 3.46. Tempus AI, Inc. has a twelve month low of $41.73 and a twelve month high of $104.32. The stock has a fifty day simple moving average of $51.29 and a 200 day simple moving average of $54.27. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. During the same period in the previous year, the business earned ($0.24) EPS. The business’s quarterly revenue was up 36.1% compared to the same quarter last year. Sell-side analysts expect that Tempus AI, Inc. will post -1.35 EPS for the current year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.